Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Other Operating Expenses (2022 - 2025)

Bioregenx has reported Other Operating Expenses over the past 4 years, most recently at $702343.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 95.81% year-over-year to $702343.0; the TTM value through Dec 2025 reached $715924.0, down 95.91%, while the annual FY2025 figure was $740924.0, 96.01% down from the prior year.
  • Other Operating Expenses for Q4 2025 was $702343.0 at Bioregenx, up from $2316.0 in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $16.8 million in Q4 2024 and troughed at $2316.0 in Q3 2025.
  • A 4-year average of $1.2 million and a median of $64903.5 in 2023 define the central range for Other Operating Expenses.
  • Biggest five-year swings in Other Operating Expenses: surged 18770.95% in 2024 and later plummeted 99.6% in 2025.
  • Year by year, Other Operating Expenses stood at $7686.0 in 2022, then skyrocketed by 1056.27% to $88871.0 in 2023, then surged by 18770.95% to $16.8 million in 2024, then plummeted by 95.81% to $702343.0 in 2025.
  • Business Quant data shows Other Operating Expenses for BRGX at $702343.0 in Q4 2025, $2316.0 in Q3 2025, and $2987.0 in Q2 2025.